Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 3/20 | 0.60 |
| ▸ | BACE1 | P56817 | 4/20 | 0.53 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.52 |
| ▸ | CASP3 | P42574 | 2/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | CASP9 | P55211 | 1/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7418200 | 0.91 | CASP1 (0.62) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL7420728 | 0.87 | CASP1 (0.57) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL9241543 | 0.85 | CASP1 (0.67) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL27825824 | 0.85 | CASP1 (0.67) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL23931322 | 0.84 | CASP1 (0.61) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL812941 | 0.84 | CASP1 (0.61) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL7416737 | 0.84 | CASP1 (0.53) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL7425546 | 0.83 | CASP1 (0.54) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL29030118 | 0.83 | CASP1 (0.64) | CASP1BACE1BACE2OPRD1CASP3 | |
| SCHEMBL18087495 | 0.82 | CASP1 (0.63) | CASP1BACE1BACE2OPRD1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080026003-A1 | Methods for inhibiting pain | THE GENERAL HOSPITAL CORPORATION (US) | 2008-01-31 | — | — | US | disclosed |
| US-20040105859-A1 | Methods for inhibiting pain | GENERAL HOSPITAL CORPORATION, THE | 2004-06-03 | — | — | US | disclosed |